Shuxin Li

Dr. Shuxin Li


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2023 in The FASEB Journal
Verified
Journal Article
Closed access
SLShuxin Li
Shuxin Li
JLJianyi Lv
Jianyi Lv
XZXing Zhang
Xing Zhang
QZQiuyu Zhang
Qiuyu Zhang
ZLZhihui Li
Zhihui Li
XDXiaoyan Du
Xiaoyan Du

29 February 2024 in Oncogenesis
Verified
Journal Article
Open access
PDF file
YLYing-Na Liao
Ying-Na Liao
YGYan-Zhi Gai
Yan-Zhi Gai
LQLi-Heng Qian
Li-Heng Qian
HPHong Pan
Hong Pan
YZYi-Fan Zhang
Yi-Fan Zhang
HNHuizhen Nie
Huizhen Nie
Endocrine receptors play an essential role in tumor metabolic reprogramming and represent a promising therapeutic avenue in pancreatic ductal adenocarcinoma (PDAC). PDAC is characterized by a nutrient-deprived microenvironment. To meet their ascendant energy demands, cancer cells can internalize extracellular proteins via macropinocytosis. However, the roles of endocrine receptors in macropinocytosis are not clear. In this study, we found that progesterone receptor (PGR), a steroid-responsive nuclear receptor, is highly expressed in PDAC tissues obtained from both patients and transgenic LSL-KrasG12D/+; LSL-Trp53R172H/+; PDX1-cre (KPC) mice. Moreover, PGR knockdown restrained PDAC cell survival and tumor growth both in vitro and in vivo. Genetic and pharmacological PGR inhibition resulted in a marked attenuation of macropinocytosis in PDAC cells and subcutaneous tumor models, indicating the involvement of this receptor in macropinocytosis regulation. Mechanistically, PGR upregulated CDC42, a critical regulator in macropinocytosis, through PGR-mediated transcriptional activation. These data deepen the understanding of how the endocrine system influences tumor progression via a non-classical pathway and provide a novel therapeutic option for patients with PDAC.

28 May 2024 in The FASEB Journal
Verified
Journal Article
Closed access
YLYing‐Na Liao
Ying‐Na Liao
PHPei‐Qi Huang
Pei‐Qi Huang
HPHong Pan
Hong Pan
YGYan‐Zhi Gai
Yan‐Zhi Gai
YZYun‐Fei Zhan
Yun‐Fei Zhan
HNHuizhen Nie
Huizhen Nie